Advanced Enzyme Technologies’ board has approved the approval to acquire additional stake of 15% of Equity Share capital of JC Biotech (70% subsidiary of the Company) (JCB) by way of purchase of 31,06,680 Equity Shares from the existing shareholder(s) of JCB for a consideration of Rs 211.25 Million i.e. Rs. 68 per Equity Share, and authorized the signing of amendment to the Shareholders' Agreement in this regard. On completion of the said investment, the shareholding of the company in JCB will increase from 70% to 85%.
Advanced Enzyme Technologies is a research driven company with global leadership in manufacturing of enzymes and probiotics. It is the largest Indian enzyme company engaged in the research and development, manufacturing and marketing of vast proprietary products developed from many indigenous enzymes & probiotics.
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1929.15 |
| Dr. Reddys Labs. | 1244.10 |
| Cipla | 1439.70 |
| Zydus Lifesciences | 1148.40 |
| Lupin | 2491.50 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: